Cara Therapeutics, Inc. (CARA) is an American biotechnology company focused on developing and commercializing novel therapeutics for the treatment of pain and pruritus. Leveraging its proprietary chemical knowledgebase and technologies targeting selective modulation of peripheral cannabinoid receptors (CB receptors), Cara Therapeutics aims to develop innovative drugs with potential therapeutic benefits and reduced risk of adverse effects.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
